NACL Industries Ltd

NACL Industries Limited has executed a Share Purchase Agreement (SPA) for the divestment of its equity shareholding in its associate company, Nasense Labs Private Limited. This follows the Board of Directors' approval granted on July 22, 2026, for the proposed sale. The execution of the SPA on August 10, 2026, marks a significant step in the company's strategy to divest its stake in this associate entity.

NACL Industries Limited has submitted its Monitoring Agency Report for the quarter ended June 30, 2026, confirming no deviation in the utilization of funds raised through its Rights Issue. The report, filed as per SEBI regulations, indicates that all proceeds were used in line with the objects stated in the Letter of Offer dated December 08, 2025. The total amount raised was ₹24,928.91 Lakhs, with allocations for repayment of borrowings, investment in its subsidiary NACL Spec-Chem Limited, general corporate purposes, and issue expenses. CRISIL Ratings Limited acted as the monitoring agency.

NACL Industries Limited has announced the voting results and scrutinizer's report for resolutions considered at a recent meeting. Key resolutions included the adoption of audited standalone and consolidated financial statements for the financial year ended March 31, 2026. Additionally, the re-appointment of Mr. Sankarasubramanian S as a director retiring by rotation was considered. The voting results indicate overwhelming support for all resolutions, with a significant majority of votes cast in favour. The remuneration of the Cost Auditors for FY2026-27 was also ratified.

NACL Industries Limited announced the approval of the sale of its entire equity stake in its associate company, Nasense Labs Private Limited, to Mr. Kanumuru Satyanarayana Raju. The transaction, valued at ₹8,15,29,967, is expected to be completed within three months, subject to the terms of the Share Purchase Agreement. Following the divestment, Nasense Labs Private Limited will no longer be an associate of NACL Industries. The company also approved its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, and a statement of deviation(s) and variation(s) regarding the utilization of funds from a December 2025 rights issue.

NACL Industries Limited's Board of Directors met on July 22, 2026, to approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The board also approved the sale of its entire equity stake in Nasense Labs Private Limited, an associate company, to Mr. Kanumuru Satyanarayana Raju for ₹8.15 crore. This divestment is expected to be completed within three months. Additionally, the board approved the Statement of Deviation(s) and Variation(s) and the Monitoring Agency Report concerning the utilization of funds from a December 2025 rights issue.

NACL Industries' Q1 FY27 (quarter ended 30 June 2026) is a bottom-line story: consolidated net profit rose 59.8% year-on-year to ₹20.84 Cr from ₹13.04 Cr, even as revenue from operations fell 14.1% to ₹383.33 Cr (₹448.36 Cr a year ago). The print is clean — no exceptional items this quarter, so the profit jump is not flattered by one-offs; the ₹17.45 Cr consolidated exceptional loss tied to discontinuing certain under-development products belongs to FY26. The profit surge is entirely margin-led: total consolidated expenses fell ~17% YoY (₹431.45 Cr to ₹356.89 Cr), outpacing the 14% revenue decline, lifting net margin to 5.4% from 2.9%. Sequentially the quarter is a turnaround — from a ₹0.86 Cr net loss in Q4 FY26 to a ₹20.84 Cr profit — with revenue up 6.7% QoQ, though for an agrochemical (crop-protection) business the April–June pre-kharif window is seasonally the strongest quarter, so part of the sequential jump is seasonality rather than a fresh demand inflection. A notable wrinkle sits below the profit line: EPS eased to ₹0.60 from ₹0.65 YoY despite the higher absolute profit, because the December 2025 rights issue (32.5M new ₹1 shares) expanded the share count faster than earnings grew — per-share metrics are diluted even as the P&L improved. Standalone profit (₹23.57 Cr, +65% YoY) ran ahead of consolidated, the ~₹2.7 Cr gap reflecting subsidiary losses (one subsidiary posted a ₹3.41 Cr net loss; the associate contributed nil). Both bases tell the same story — revenue down low-double-digits, profit up ~60% on cost-led margin gains — so there is no material standalone/consolidated divergence. Management gives no formal guidance and there is no prior concall or outlook on record, so the print can only be judged on its own merits; no analyst consensus is published for a name this size, so a beat/miss versus street cannot be established. Alongside the results the Board approved divesting the company's entire stake in associate Nasense Labs to Mr. K. Satyanarayana Raju for ₹8.15 Cr (expected to close within three months) and cleared the deviation statement on Rights Issue fund utilisation — ₹24.45 Cr of the rights proceeds remains unutilised, parked in an earmarked bank account. The core question the numbers leave open is whether the topline contraction is demand-driven or a deliberate mix/portfolio shift, and whether the fresh margin level holds.

NACL Industries Ltd has announced that its Board of Directors will convene on July 22, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026 (Q1 FY27), both standalone and consolidated. Concurrently, the company has closed its trading window from July 1, 2026, to July 24, 2026, in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. This period covers the announcement of the financial results.

NACL Industries Limited has informed the exchange about a significant surge in its share price and trading volume between June 19 and June 30, 2026. The company provided data on the number of trades, deliverable quantity, percentage of deliverable to traded quantity, and high price for several trading days. This disclosure follows previous communications with the exchange regarding price and volume movements. NACL Industries reiterates its compliance with SEBI regulations and timely disclosure of material information.

NACL Industries Limited has published a newspaper advertisement announcing the details of its 39th Annual General Meeting (AGM). The AGM will be held on Wednesday, July 22, 2026, at 03:30 p.m. The meeting will be conducted through Video Conferencing/ Other Audio Visual Means (VC/OAVM) facility, in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The advertisements were published in 'Business Standard' (English) and 'Andra Prabha' (Telugu) on June 30, 2026.

NACL Industries Limited has announced the details for its 39th Annual General Meeting (AGM), scheduled for Wednesday, July 22, 2026, at 3:30 p.m. IST, to be conducted via Video Conferencing/Other Audio-Visual Means. The company has also electronically dispatched the Notice convening the AGM along with the Annual Report for the Financial Year 2025-26 to its members. The Annual Report highlights a transformational year for NACL, marked by Coromandel International's acquisition of a controlling stake, integrating NACL into the Murugappa Group. This strategic move aims to leverage NACL's manufacturing capabilities with Coromandel's distribution network for accelerated growth and enhanced value creation. E-voting details are also provided, with a cut-off date of July 17, 2026.